Europe — EMA
Myoqinon (Ubidecarenone)
GNH USA supplies Myoqinon (Ubidecarenone), a coenzyme Q10 supplement for cardiovascular health and antioxidant protection. Request a quote for global supply.
Request sourcing
What is Ubidecarenone?
Ubidecarenone, the active ingredient in Myoqinon, is a coenzyme Q10 (ubiquinone) presented as an oral supplement for oral use. It supports cardiovascular health, cellular energy metabolism and provides antioxidant protection for adults.\n\nGNH India supplies Myoqinon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Ubidecarenone used for?
Myoqinon (ubidecarenone) is used to support physiological pathways related to cardiovascular function, cellular energy production, and oxidative stress.\n\nCardiovascular health: helps maintain normal heart function and blood vessel health.\nCellular energy metabolism: contributes to ATP production in mitochondria, supporting overall energy levels.\nOxidative stress: provides antioxidant protection to cellular membranes.
What are the side effects of Ubidecarenone?
Like other nutritional supplements, ubidecarenone may be associated with occasional adverse reactions.\n\nCommon Side Effects:\n- Gastrointestinal upset (nausea, dyspepsia)\n- Loss of appetite\n- Headache\n- Insomnia\n- Skin rash or itching\n- Metallic taste in the mouth\n\nSerious or Rare Side Effects:\n- Elevated liver enzymes\n- Severe allergic reaction (anaphylaxis)\n- Significant blood pressure changes\n- Muscle weakness or myopathy\n- Thrombocytopenia\n- Cardiac arrhythmia
What precautions apply to Ubidecarenone?
Before initiating Myoqinon, consider the following precautions.\n\nMedical review: assess liver function prior to therapy.\nPregnancy: safety not established; avoid unless benefits outweigh risks.\nConcurrent anticoagulants: monitor bleeding risk closely.\nKidney impairment: adjust use based on clinical judgment.\nDrug interactions: review all concomitant medications for potential interactions.\nStore at ambient temperature: keep in the original pack, protect from moisture and light.
What does Ubidecarenone interact with?
Ubidecarenone can interact with several medicines; monitoring is advised.\n\nMajor Interactions (Avoid):\n- Warfarin: may increase anticoagulant effect.\n- Chemotherapy agents (e.g., cyclophosphamide): may reduce efficacy.\n- Statins: potential for increased muscle toxicity.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: may enhance hypotensive effect.\n- Antihypertensives: monitor blood pressure.\n- Diabetes medications: possible alteration of glucose control.
